Table 1

Patient and aneurysm characteristics

Patient and aneurysm characteristics
Patient NoAneurysm
location* (ICA)
Transverse
diameter (mm)
Height
(mm)
StentLocalization of ISS†Inadequate appositionPrevious
treatment
RROC
STFU
RROC
LTFU
Stenosis
STFU (%)
Stenosis
LTFU (%)
1C43.63.4FRProximal112017
2C74.84.4FRDistal114312
3C63.73.5FRProximal33218
4C64.24FRMid113127
5C62.23.2FRMid32296
6C622DRMidYes112519
7C64.13.2PFMidCoils11238
8C62.73.1PFMid11364
9C64.88.7PFMid21294
10C510.316.2FRMid32102
11C62.72.5PFMidCoils31463
12C669DRMid11280
13C63.83.3PFMid115826
14C64.23.9PFDistal114922
15C73.34.3DRMid11124
16C63.44.5DRMid114328
17C63.13.5DRProximal211515
18C744.3DRMid113721
  • *According to the Bouthillier classification.

  • †In relation to the stent.

  • DR, Derivo (Acandis, Germany); FR, FRED (MicroVention, USA); ICA,  internal  carotid artery; ISS, in-stent stenosis; LTFU, long term follow-up; PF, Pipline Flex (Medtronic, USA);  RROC, Raymond–Roy Occlusion Rate; STFU, short term follow-up.